Literature DB >> 24104691

The antimicrobial effects and metabolomic footprinting of carboxyl-capped bismuth nanoparticles against Helicobacter pylori.

P Nazari1, R Dowlatabadi-Bazaz, M R Mofid, M R Pourmand, N E Daryani, M A Faramarzi, Z Sepehrizadeh, A R Shahverdi.   

Abstract

Organic salts of bismuth are currently used as antimicrobial agents against Helicobacter pylori. This study evaluated the antibacterial effect of elemental bismuth nanoparticles (Bi NPs) using a serial agar dilution method for the first time against different clinical isolates and a standard strain of H. pylori. The Bi NPs were biologically prepared and purified by a recently described method and subjected to further characterization by infrared spectroscopy and anti-H. pylori evaluation. Infrared spectroscopy results showed the presence of carboxyl functional groups on the surface of biogenic Bi NPs. These biogenic nanoparticles showed good antibacterial activity against all tested H. pylori strains. The resulting MICs varied between 60 and 100 μg/ml for clinical isolates of H. pylori and H. pylori (ATCC 26695). The antibacterial effect of bismuth ions was also tested against all test strains. The antimicrobial effect of Bi ions was lower than antimicrobial effect of bismuth in the form of elemental NPs. The effect of Bi NPs on metabolomic footprinting of H. pylori was further evaluated by (1)H NMR spectroscopy. Exposure of H. pylori to an inhibitory concentration of Bi NPs (100 μg/ml) led to release of some metabolites such as acetate, formic acid, glutamate, valine, glycine, and uracil from bacteria into their supernatant. These findings confirm that these nanoparticles interfere with Krebs cycle, nucleotide, and amino acid metabolism and shows anti-H. pylori activity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24104691     DOI: 10.1007/s12010-013-0571-x

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  8 in total

1.  Antimicrobial and anti-biofilm activities of Bi subnitrate and BiNPs produced by Delftia sp. SFG against clinical isolates of Staphylococcus aureus, Pseudomonas aeruginosa, and Proteus mirabilis.

Authors:  Mojtaba Shakibaie; Elnaz Hajighasemi; Mahboubeh Adeli-Sardou; Mohsen Doostmohammadi; Hamid Forootanfar
Journal:  IET Nanobiotechnol       Date:  2019-06       Impact factor: 1.847

Review 2.  Nanoparticles of Bioactive Metals/Metal Oxides and Their Nanocomposites with Antibacterial Drugs for Biomedical Applications.

Authors:  Tatyana Shabatina; Olga Vernaya; Aleksei Shumilkin; Alexander Semenov; Mikhail Melnikov
Journal:  Materials (Basel)       Date:  2022-05-18       Impact factor: 3.748

Review 3.  Potential applications of engineered nanoparticles in medicine and biology: an update.

Authors:  Gudepalya Renukaiah Rudramurthy; Mallappa Kumara Swamy
Journal:  J Biol Inorg Chem       Date:  2018-08-10       Impact factor: 3.862

4.  Inhibitory Effect of Bismuth Oxide Nanoparticles Produced by Bacillus licheniformis on Methicillin-Resistant Staphylococcus aureus Strains (MRSA).

Authors:  Leila Firouzi Dalvand; Farzaneh Hosseini; Shahram Moradi Dehaghi; Elham Siasi Torbati
Journal:  Iran J Biotechnol       Date:  2018-12-12       Impact factor: 1.671

5.  1H nuclear magnetic resonance-based metabolite profiling of guava leaf extract: an attempt to develop a prototype for standardization of plant extracts.

Authors:  Manasi S Gholkar; Jia V Li; Poonam G Daswani; P Tetali; Tannaz J Birdi
Journal:  BMC Complement Med Ther       Date:  2021-03-18

6.  Nystatin-mediated bismuth oxide nano-drug synthesis using gamma rays for increasing the antimicrobial and antibiofilm activities against some pathogenic bacteria and Candida species.

Authors:  Ahmed I El-Batal; Hanady G Nada; Reham R El-Behery; Mohamed Gobara; Gharieb S El-Sayyad
Journal:  RSC Adv       Date:  2020-03-05       Impact factor: 4.036

Review 7.  Metal nanoparticles: understanding the mechanisms behind antibacterial activity.

Authors:  Yael N Slavin; Jason Asnis; Urs O Häfeli; Horacio Bach
Journal:  J Nanobiotechnology       Date:  2017-10-03       Impact factor: 10.435

8.  Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues.

Authors:  Bhavesh D Kevadiya; Brendan Ottemann; Insiya Z Mukadam; Laura Castellanos; Kristen Sikora; James R Hilaire; Jatin Machhi; Jonathan Herskovitz; Dhruvkumar Soni; Mahmudul Hasan; Wenting Zhang; Sarella Anandakumar; Jered Garrison; JoEllyn McMillan; Benson Edagwa; R Lee Mosley; Richard W Vachet; Howard E Gendelman
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.